Bosco-Lévy P

ORCID: 0000-0001-9763-5974 · 1 paper in corpus
2019
British journal of clinical pharmacology ·doi:10.1111/bcp.14027

AimsIn 2017, concerns regarding adverse events (AEs) associated with the Mirena levonorgestrel intrauterine device were largely echoed in the media in France. This resulted in a tremendous reporting of AEs to pharmacovigilance centres. The …